Synaptogenix Inc. has announced a $5.5 million equity investment through securities purchase agreements involving the sale of 5,500 shares of its newly issued Series D convertible preferred stock. This preferred stock, with a stated value of $1,000 per share, is convertible into common stock and comes with five-year common stock purchase warrants, all set with a conversion and exercise price of $3.00 per share. Notably, prominent investor James Altucher is involved in this financing, which is expected to close around June 10, 2025, pending customary closing conditions. This investment aligns with Synaptogenix's strategy to bolster its digital asset treasury, focused on the AI token TAO.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Synaptogenix Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY05605) on June 09, 2025, and is solely responsible for the information contained therein.